Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13216-13226
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13216
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13216
Table 3 Clinical characteristics of the subjects enrolled
| Characteristic | All | |
| Reinfection, n (%) | 1 (6.67) | |
| Predicted source of infection, n (%) | ||
| Family | 3 (20) | |
| Patient | 3 (20) | |
| Coworker | 7 (46.67) | |
| Unknown | 2 (13.34) | |
| Mask usage during outside activity, n (%) | ||
| Surgical mask | 11 (73.34) | |
| N95 mask | 3 (20) | |
| KN95 mask | 1 (6.67) | |
| Symptoms, n (%) | ||
| Fever | 10 (66.67) | |
| Cough | 7 (46.67) | |
| Rhinorrhea | 9 (60) | |
| Headache | 5 (33.34) | |
| Sore throat | 2 (13.34) | |
| Anosmia | 8 (53.34) | |
| Ageusia/Dysgeusia | 4 (26.67) | |
| Diarrhea | 3 (20) | |
| Fatigue | 4 (26.67) | |
| Myalgia | 4 (26.67) | |
| Dyspnea | 1 (6.67) | |
| Nausea | 1 (6.67) | |
| Time in d of symptom duration, mean ± SD | 7.73 ± 5.444 | |
| Time in d of PCR conversion, mean ± SD | 17.93 ± 6.364 | |
| Time in d that elapsed from second dose of vaccine to a positive PCR result, median IQR | 87 (86-128.00) | |
| In-home isolation, n (%) | 15 (100) | |
| Drug treatment, n (%) | ||
| Vitamin C | 14 (93.34) | |
| Vitamin D | 12 (80) | |
| Paracetamol | 8 (53.34) | |
| Azithromycin | 5 (33.34) | |
| Oseltamivir | 1 (6.67) | |
| Favipiravir | 3 (20) | |
| Phytopharmaca | 1 (6.67) | |
- Citation: Karuniawati A, Syam AF, Achmadsyah A, Ibrahim F, Rosa Y, Sudarmono P, Fadilah F, Rasmin M. Case series in Indonesia: B.1.617.2 (delta) variant of SARS-CoV-2 infection after a second dose of vaccine. World J Clin Cases 2022; 10(36): 13216-13226
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13216.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13216